Every nutraceutical brand uses some combination of these tactics to make their evidence look stronger than it is. Here's what to watch for on this product specifically.
⚑ Excluded the condition being studied
Excluded androgenetic alopecia from the hair-loss study
Viviscal is sold to people with pattern hair loss — the most common cause of hair loss in the world. The published trials excluded it. Verbatim from their 2015 study, the exclusion criteria removed 'androgenetic alopecia (determined by clinical exam, patient and family history).' They recruited women with 'self-perceived thinning,' then screened out androgenetic alopecia and telogen effluvium. After removing every actual diagnosis, what's left is a group defined by perception — exactly the population most likely to recover on its own.
⚑ Larger study no effect
The bigger study showed no effect — at all
Viviscal's brand summaries list a 1997 study in 200 men with androgenetic alopecia — 10× larger than the 15-person RCTs they cite in marketing. The result wasn't 'hair counts doubled.' The surviving brand-facing claim is softer: 75.3% reported decreased hair loss; 14.6% showed partial regrowth. A later review of the available data calculated the actual hair-count increase at ~4%, statistically non-significant. When the sample size got bigger and the population was actual pattern hair loss, the effect didn't shrink — it disappeared.
⚑ Small N
The most-cited 'RCT' had 15 people
Viviscal's headline 2012 randomized trial randomized 15 subjects: 10 on the supplement, 5 on placebo. You cannot conclude anything from a five-person control group. By comparison, the finasteride pivotal trials had n=1,553.
⚑ Questionnaire spin
'Improved in 10 of 12 items' was actually 3 of 12 significant
The 2015 study trumpets that subjects 'improved in 10 of 12 items' on the self-assessment. The fine print: only 3 of 12 reached statistical significance over placebo. 'Improved in 10 of 12' converts nine non-results into wins via descriptive direction-of-effect framing.
⚑ Cherry-picked photos
Two hand-picked subjects per study
Every Viviscal study published before-and-after photos for exactly two subjects. Never the full group. You see the two best responders; you never see the people who didn't respond. With n=10–15 active-arm subjects, the difference between the median and the best result can be enormous.
⚑ Blinding not disclosed
Nobody discloses who counted the hairs — or whether they were blinded
In studies where the entire result is a hand-counted hair number, none of the published Viviscal trials state whether the hair counts were performed blind to treatment assignment, or who performed them. The one number that matters is the one with no methodology controls disclosed.
⚑ Old foundational study
The headline '38% increase' is from 1992 — and uncontrolled
Viviscal marketing still cites the 1992 Lassus study, which had no placebo arm, no blinding, and 30 participants. Modern statistical standards would not consider that supportive evidence.
⚑ Sponsored
Every modern trial is manufacturer-funded
All published Viviscal RCTs were sponsored by Lifes2good or Church & Dwight. Zero independent replication.
⚑ No active comparator
Never compared to minoxidil — or to a basic multivitamin
In over 30 years on the market, Viviscal has never been compared head-to-head with finasteride, minoxidil, or even a basic multivitamin. We have no idea how it stacks up against the alternatives.
⚑ Regulatory action
NAD forced Viviscal to drop its 91% claim
In 2015, the National Advertising Division required Viviscal to drop its '91% of women noticed thicker, fuller hair' claim, finding the claim was not supported by the underlying data. NAD is the advertising industry's self-regulatory body; their rulings carry weight with the FTC.
⚑ Shared sponsor investigator
The same dermatologist authored Viviscal's and Nutrafol's pivotal trials
The dermatologist who authored most of the published Viviscal trials also authored Nutrafol's pivotal trials. Same investigator, two competing brands, a small sponsor-funded circle producing the published 'clinical evidence' for the entire hair-supplement category.
⚑ Proprietary blend
AminoMar marine complex composition is undisclosed
The marine complex is a black box. You can't reproduce the studies without buying the product. No independent group has isolated the active component.
